the prevalence of anti-ofa-i with the ia method was 78 % ( 21/27 ) in total hydatidiform mole , 80 % ( 8/10 ) in invasive mole and 86 % ( 28/32 ) in choriocarcinoma patients .
C0020217
hydatidiform mole
C0008493
invasive